RePORT International Resources

Several training packages.

This three-part webinar series by the Stop TB Partnership and FIND provides an in-depth overview of targeted next-generation sequencing (tNGS) technology for detecting drug-resistant tuberculosis. The series covers fundamental principles of tNGS, its advantages over traditional diagnostic methods, and practical guidance on implementing tNGS in high-burden and resource-limited settings. Featuring expert insights and case studies, the webinars highlight early program experiences and discuss how tNGS supports WHO-endorsed strategies to improve rapid and comprehensive detection of TB drug resistance worldwide.

This website features TAG’s latest updates in the fight to end HIV/AIDS, Hepatitis C, and Tuberculosis. It includes the Pipeline Report on innovations in diagnosing, preventing, treating, and curing HIV, HCV, and TB; information on TB research funding; recorded webinars; advocacy letters and comments submitted or endorsed by TAG; and official press releases and statements.

Please refer to the link for the TAG's latest edition of TB Treatment Pipeline Report. The report provides the latest information on 22 new or repurposed drugs in clinical development for TB and summarizes ongoing, planned, and recently completed trials. Included in this year's report are: Results from the phase 3 endTB-Q trial and two phase 2b/c trials of quabodepistat-containing regimens completed or discontinued in 2024; First-of-their-kind trials focused on asymptomatic TB and bedaquiline-resistant TB; The first long-acting formulation of a TB drug to enter clinical development; and The first phase 3 trial of a new drug from a new class since bedaquiline and delamanid.

The new 2025 update of An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis lays out what community advocates need to know about WHO-recommended regimens for drug-resistant TB. The Activist Guide reviews the evidence-base behind these regimens, important considerations for key populations affected by TB, the access landscape, and more. The publication is intended to equip advocates with information they need to formulate arguments and push for universal implementation of the best available treatments.

TAG’s Cheat Sheets for Tuberculosis Activists are designed to help advocates navigate the range of tools in use and in the research pipeline.

To accompany the updated Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis, TAG also developed three additional educational materials to support community-based and civil society organizations leading treatment literacy, peer support, and community-led monitoring activities:

The World Health Organization (WHO) guidelines for diagnosing TB have evolved along with available technologies and tools that are increasingly accurate, simple, and efficient at detecting TB and resistance to a wider range of TB drugs. Despite this progress, 2.7 million individuals with TB still remain undiagnosed and undetected. On July 17th, 2025, TAG hosted a community webinar on tests for TB and drug resistance. The webinar breaks down the latest WHO guidelines and explores the most effective tools for diagnosing TB and drug resistance. The webinar also launched TAG’s updated resource, An Activist’s Guide to Diagnostic Tools for Tuberculosis, and provides a deep dive into two sections of the Guide: (1) the array of WHO-recommended diagnostic tools and how they should be optimally used in country programs; and (2) key access considerations and actions activists can take to ensure that all people at risk of TB receive quality TB diagnostic testing.

The Tuberculosis Data, Impact Assessment and Communications Hub (TB DIAH) supports decision-makers by generating, analyzing, and utilizing quality data to inform and scale up effective TB services. This website provides resources on TB M&E and surveillance processes.

A report has been published based on findings of the study conducted in Ukraine: “Studying the Aspects of Gender, Equity, and Inclusion in the Workplace Among Healthcare Professionals Involved in TB Response" https://tbcoalition.eu/resource/files/2025/09/report-on-gender-assessment-among-healthcare-workers-in-ukraine_eng.pdf The aim of the study was to assess the level of implementation of gender equality principles among healthcare workers providing TB diagnostic and treatment services, and to examine the barriers preventing women and men from exercising their right to gender equality. The study employed a triangulation method, which ensured the validity and reliability of the results. As part of this approach, the following methods were used: Desk review, In-depth interviews, Focus group discussions.

National Association of Tuberculosis Patients of the Republic of Moldova “SMIT” published a report with the results of the study ‚ Multidimensional Analysis of Tuberculosis-Related Stigma in the Republic of Moldova. The study was conducted at the request of the National TB Response Program, with the support of the Center for Health Policies and Studies and the TB Europe Coalition, and funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria and the Stop TB Partnership. The assessment was conducted in 2025 and provides a structured analysis of the barriers to accessing human rights-based, gender-sensitive, and population-specific TB care.

This website features TBEC's resources ranging from different publications to various capacity building tools such CSOs map or TBEC webinar recordings, please see below a short overview of different international and regional institutions and organisations, fighting against TB in the WHO Europe region and globally. All of the websites contain valuable sources of information and capacity building tools that you will find helpful in your advocacy in the WHO Europe region and globally.

TBEC’s mission is to strengthen the role and contribution of civil society organisations (CSOs) and affected communities within a sustainable and effective response to TB across in the region by: Providing a coordinating body that unites TB advocates across the region, in order to disseminate information, promote collaboration and learning, and share best practice; Building the advocacy capacity and coordinate the strategies of TB advocates and CSOs across the region; Leveraging the political and financial commitment

Treatment Action Group (TAG) and the Community Research Advisors Group (CRAG) released the TB Representative Studies Rubric (TB RSR), a new tool that community advisory boards (CABs) can use when designing and reviewing clinical trials protocols. The TB RSR is a 17-item questionnaire that assesses whether TB treatment trials include the types of people who get TB. By documenting the representativeness of TB studies, community advisors and researchers can work together to ensure that all people in need of safe and effective options for treating and preventing TB can benefit from research.

This catalog provides a listing of each course, seminar series, and other training modalities offered by each TRAC that are open to the TB community. Just as a university or college course catalog is divided into the offerings provided by a given department, the TRAC Train catalog lists the virtual, hybrid, and in-person seminar series, journal clubs, classes/workshops, and other events that are offered by each TRAC.

A three-part online study club series, hosted by the Diagnostics Equity Consortium (DEC) and the Global TB Community Advisory Board (TB CAB), explores the evolving TB diagnostic landscape and strategies to expand testing coverage. Session one addresses the TB testing gap and emerging diagnostic tools. Session two focuses on optimizing national diagnostic networks and test distribution. Session three examines the impact and trade-offs of near- and point-of-care TB tests in expanding access.

TBnet is a European grass-root consortium consisting of health care professionals and scientists, aimed at promoting quality of care for tuberculosis patients by addressing health-inequalities, providing expert guidance in areas where clinical evidence is missing, defining research priorities, conducting multicenter clinical studies, and training early career European clinicians and scientists.

This webinar recording from TB Net occurred in July 2025.

Implementation research (IR) is important for designing strategies or solutions to overcome bottlenecks that prevent proven and innovative public health interventions from reaching the people who need them. This ensure that these interventions are used in a manner that results in the outcome for which they were intended. Such solutions include how to overcome barriers to adoption of drugs, diagnostics or preventive measures that improve health for people at risk of malaria, tuberculosis, NTDs or other infectious diseases. IR can help to ensure that health solutions reach the people who need them and are used in ways that generate intended results. This course is a step-by-step online training for public health researchers and decision-makers, disease control programme managers, academics and others that focuses on how to design and demonstrate robust IR projects to improve control of infectious diseases of poverty and generate better health outcomes.

TDR supports effective and innovative global health research, through strengthening the research capacity of disease-affected countries, and promoting the translation of evidence into interventions that reduce the burden of infectious diseases and build resilience in the most vulnerable populations